AEON Biopharma (AEON) Proxy Filing summary

Executive summary

• Supplement updates the quorum requirement for the 2025 Annual Meeting to 33.34% of voting power, correcting a previous statement of a majority requirement.

• The Annual Meeting is scheduled for June 13, 2025, at 10:00 a.m. Pacific Time.

• No other changes have been made to the Proxy Statement aside from the quorum clarification.

Voting matters and shareholder proposals

• Board continues to recommend stockholders vote as outlined in the original Proxy Statement.

• Proxies already submitted remain valid unless revoked or changed.

Shareholder rights and capital structure

• Only Class A Common Stock is outstanding, with 10,646,615 shares as of the record date.

• Quorum for the meeting is now 33.34% of voting power, present in person or by proxy.

• Broker non-votes are counted as present for quorum purposes.

• If a quorum is not present, the meeting may be adjourned until a quorum is achieved.